SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-12-047635
Filing Date
2012-08-28
Accepted
2012-08-28 13:03:33
Documents
2
Period of Report
2012-08-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DYNAVAX ANNOUNCES FDA ADVISORY COMMITTEE TO REVIEW HEPLISAV rrd354566.htm 8-K 12780
2 PRESS RELEASE DATED AUGUST 28, 2012, TITLED "DYNAVAX ANNOUNCES FDA ADVISORY COMM rrd354566_38380.htm EX-99 6178
  Complete submission text file 0001181431-12-047635.txt   20060
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 121059245
SIC: 2834 Pharmaceutical Preparations